'Designer reagents' recombinant microorganisms: new and powerful tools for organic synthesis

Tetrahedron

Volumn 65, Issue 5, 2009, Pages 947-974

  Kayser, Margaret M ^a  

^a UNIVERSITY OF NEW BRUNSWICK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYACETOPHENONE MONOOXYGENASE; ALIPHATIC KETONE MONOOXYGENASE; CYCLODODECANONE MONOOXYGENASE; CYCLOHEXANONE MONOOXYGENASE; CYCLOPENTADECANONE MONOOXYGENASE; CYCLOPENTANONE MONOOXYGENASE; DELTA VALEROLACTONE; GAMMA BUTYROLACTONE; HYBRID PROTEIN; LACTONE; PHENYLACETONE MONOOXYGENASE; REAGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; STEROID MONOOXYGENASE; UNCLASSIFIED DRUG; UNSPECIFIC MONOOXYGENASE;

BAEYER VILLIGER REACTION; BIOTRANSFORMATION; CATALYSIS; CELL GROWTH; CELL TRANSFORMATION; CHEMICAL STRUCTURE; ENANTIOSELECTIVITY; ENZYME IMMOBILIZATION; ENZYME ISOLATION; ENZYME STRUCTURE; GENE EXPRESSION SYSTEM; GENOME; MICROORGANISM; MOLECULAR EVOLUTION; NONHUMAN; ORGANIC CHEMISTRY; OXIDATION; PRIORITY JOURNAL; REVIEW;

EID: 57749198860     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2008.10.039     Document Type: Review

References (268)

1. Johnson C.R. Acc. Chem. Res. 31 (1998) 333-341
2. Santaniello E., Ferraboschi P., Grisenti P., and Manzocchi A. Chem. Rev. 92 (1992) 1071-1140
3. Roberts S.M., and Turner N.J. In: Servi S. (Ed). Use of Enzymes as Catalysts in Key Reactions Leading to the Synthesis of Optically Active Natural Products and Analogues in Microbial Reagents in Organic Synthesis (1992), Kluwer Academic, The Netherlands 93-111
4. Patel R.N. Food Technol. Biotechnol. 42 (2004) 305-325
5. Vasic-Racke D. In: Liese A., Seelbach K., and Wandry C. (Eds). History of Industrial Biotransformations: Dreams and Realities in Industrial Biotransformations. 2nd ed. (2006), Wiley-VCH GmbH, Weinheim
6. Bornscheuer U.T., and Buchholtz K. Eng. Life Sci. 5 (2005) 309-323
7. Hari Krishna S., and Karanth N.G. Catal. Rev. 44 (2002) 499-591
8. Bornscheuer U.T., and Kazlauskas R.J. Hydrolases in Organic Synthesis (2006), Wiley-VCH, Weinheim
9. Anderson E.M., Larsson K.M., and Kirk O. Biocatal. Biotrans. 16 (1998) 181-204
10. Gotor V. Bioorg. Med. Chem. 7 (1999) 2189-2197
11. Faber K. Biotransformations in Organic Chemistry. 5th ed. (2004), Springer, Berlin
12. In: Drauz K., and Waldmann H. (Eds). Enzyme Catalysis in Organic Synthesis (2002), Wiley-VCH, Weinheim
13. Bommarius A.S., and Riebel-Bommarius B.R. Biocatalysis: Fundamentals and Applications. 1st ed. (2004), Wiley-VCH
14. Buchholz K., Kasche V., and Bornscheuer U.T. Biocatalysts and Enzyme Technology (2005), Wiley-VCH, Weinheim
15. In: Gotor V., Alfonso I., and García-Urdiales E. (Eds). Asymmetric Organic Synthesis with Enzymes (2008), Wiley-VCH GmbH, Weinheim
16. (accessed 11.08.08). NOTE. A good discussion outlining importance, advantages, and drawbacks of biocatalysis can be found in. Bornmarius A.S., and Riebel B.R. Introduction to Biocatalysis. Biocatalysis (2004) 1-18 (accessed 28.01.05)
17. Hudlicky T. J. Braz. Chem. Soc. 9 (1998) 313-318
18. Roberts S.M. J. Chem. Soc., Perkin Trans. 1 (2000) 611-633
19. Davies B.G., and Boyer V. Nat. Prod. Rep. 18 (2001) 618-640
20. Dedicated issues on Biocatalysis and Biocatalysts in Synthetic Organic Chemistry:. Tetrahedron 60 (2004) 483-806
21. Can. J. Chem. 80 (2002) 529-752
22. Curr. Org. Chem. 10 (2006) 1051-1193
23. Roberts R.M. Tetrahedron 60 (2004) 499-500
24. Servi S. Synthesis (1990) 1-25
25. Csuk R., and Glanzer B.I. Chem. Rev. 91 (1991) 49-97
26. Kayser M.M., Yang Y., Mihovilovic M.D., Feicht A., and Rochon F.D. Can. J. Chem. 80 (2002) 796-800
27. Baeyer A., and Villiger V. Chem. Ber. 32 (1899) 3625-3633
28. For general reviews on Baeyer-Villiger oxidations, see:
29. Krow G.R. Org. React. 43 (1993) 251-798
30. Renz M., and Meunier B. Eur. J. Org. Chem. (1999) 737-750
31. Mihovilovic M.D., Rudroff F., and Grötzel B. Curr. Org. Chem. 8 (2004) 1057-1069 (A short but pertinent discussion on Baeyer-Villiger reaction and its place in biocatalysis)
32. Trudgill P.W. In: Gibson D.T. (Ed). Microbial Degradation of the Alicyclic Ring. Structural Relationships and Metabolic Pathway (1984), Marcel Dekker, New York, NY 131-180
33. Stewart J.D. Curr. Org. Chem. 2 (1998) 195-216
34. Kamerbeek N.M., Janssen D.B., Van Berkel W.J.H., and Fraaije M.W. Adv. Synth. Catal. 345 (2003) 667-678
35. Donoghue N., Norris D., and Trudgill P.W. Eur. J. Biochem. 63 (1976) 175-192
36. Ryerson C.C., Ballou D.P., and Walsh C.T. Biochemistry 21 (1982) 2644-2655
37. Branchaud B.P., and Walsh C.T. J. Am. Chem. Soc. 107 (1985) 2153-2161
38. Latham J.A., and Walsh C.T. J. Am. Chem. Soc. 109 (1987) 3421-3427
39. Schwab J.M. J. Am. Chem. Soc. 103 (1981) 1876-1878
40. Schwab J.M., Li W.-B., and Thomas L.P. J. Am. Chem. Soc. 105 (1983) 4800-4808
41. Chen Y.-C.J., Peoples O.P., and Walsh C.T. J. Bacteriol. 170 (1988) 781-789
42. Taschner M.J., and Black D.J. J. Am. Chem. Soc. 110 (1988) 6692-6693
43. Taschner M.J., and Chen Q.Z. Bioorg. Med. Chem. Lett. 1 (1991) 535-538
44. Alphand V., Archelas A., and Furstoss R. Tetrahedron Lett. 30 (1989) 3663-3664
45. Alphand V., Archelas A., and Furstoss R. J. Org. Chem. 55 (1990) 347-350
46. Abril O., Ryerson C.C., Walsh C.T., and Whitesides G.M. Bioorg. Chem. 17 (1989) 41-52
47. Ouazzani-Chahdi J., Buisson D., and Azerad R. Tetrahedron Lett. 28 (1987) 1109-1112
48. Sandey H., and Willetts A. Biotechnol. Lett. 11 (1989) 615-620
49. Königsberger K., Braunegg G., Faber K., and Griengl H. Biotechnol. Lett. 12 (1990) 509-514
50. Shipston N.F., Lenn M.J., and Knowles C.J. J. Microbiol. Methods 15 (1992) 41-52
51. Lenn M.J., and Knowles C.J. Enzyme Microb. Technol. 16 (1994) 964-969
52. Beecher J., Richardson P., and Willetts A. Biotechnol. Lett. 16 (1994) 909-912
53. Gagnon R., Grogan G., Roberts S.M., Villa R., and Willetts A.J. J. Chem. Soc., Perkin Trans. 1 (1995) 1505-1511
54. Gagnon R., Grogan G., Groussain E., Pedragosa-Moreau S., Richardson P.F., Roberts S.M., Willetts A.J., Alphand V., Lebreton J., and Furstoss R. J. Chem. Soc., Perkin Trans. 1 (1995) 2527-2528
55. To create enantioselective chemical Baeyer-Villiger reagents, several transition metal-based oxidants were prepared and investigated in the 90s and, in some cases, important asymmetric induction was achieved. For reasonably good results, however, the stereocenter had to be in close proximity of the reacting carbonyl group:. Gusso A., Baccin C., Pinna F., and Strukul G. Organometallics 13 (1994) 3442-3451
56. Bolm C., Schlingloff G., and Bienewald F. J. Mol. Catal. A: Chem. 117 (1997) 347-350
57. Bolm C., Schlingloff G., and Weickhardt K. Angew. Chem., Int. Ed. Engl. 33 (1994) 1848-1849
58. Lopp M., Paju A., Kanger T., and Pehk T. Tetrahedron Lett. (1996) 7583-7586
59. Pal R.B., and Kale V.V. J. Postgrad. Med. 27 (1981) 218-221
60. The overmetabolism encountered in the whole-cell transformations arises from the fact that the lactone product is hydrolyzed by lactone hydrolase enzymes present in the cells. Several approaches have been employed to circumvent this problem: use of lactone hydrolase inhibitor (tetraethyl pyrophosphate), replacing Acinetobacter sp. NCIB 9871 with Acinetobacter TD 63, the lactone hydrolase deficient strain; and finally, the discovery that the lactone products of 'unnatural substrates' are often quite resistant to hydrolysis. (. Furstoss R. ). In: Servi S. (Ed). Microbial Reagents in Fine Organic Synthesis (1992), Kluver Academic, Netherland 333-346 )
61. Highly accessible description of the underlying methodology is presented in the review 'A Chemist's Perspective on the Use of Genetically Engineered Microbs as Reagents for Organic Synthesis'. Stewart J.D. Biotechnol. Genet. Eng. Rev. 14 (1997) 67-143
62. Stewart J.D., Reed K.W., and Kayser M.M. J. Chem. Soc., Perkin Trans. 1 (1996) 755-757
63. Stewart J.D. Curr. Opin. Biotechnol. 11 (2000) 363-368
64. Stewart J.D., Reed K.W., Zhu J., Chen G., and Kayser M.M. J. Am. Chem. Soc. 120 (1998) 3541-3548
65. Stewart J.D., Reed K.W., Martinez C.A., Zhu J., Chen G., and Kayser M.M. J. Org. Chem. 61 (1996) 7652-7653
66. Kayser M.M., Chen G., and Stewart J.D. J. Org. Chem. 63 (1998) 7103-7106
67. Kayser M.M., Chen G., Mihovilovic M.D., Mtstik M.E., Martinez C.A., and Stewart J.D. New J. Chem. 23 (1999) 827-832 NOTE. Enzymes for biocatalysis are obtained by isolating the protein from a bacterial strain that the screening of the microorganisms shows to perform the desired reaction. Protein is purified, sequences and the amino acid sequence data are used to design primers for initial cloning and sequencing. Then, the gene is overexpressed in a heterologous host such as E. coli
68. Kayser M.M., Chen G., and Stewart J.D. Synlett (1999) 153-158
69. Mihovilovic M.D., Müller B., Kayser M.M., Stewart J.D., Fröhlich J., Stanetty P., and Spreitzer H. J. Mol. Catal. B: Enzym. 11 (2001) 349-353
70. Mihovilovic M.D., Chen G., Wang S., Kyte B., Rochon F.D., Kayser M.M., and Stewart J.D. J. Org. Chem. 66 (2001) 733-738
71. Mihovilovic M.D., Mueller B., Kayser M.M., Stewart J.D., and Stanetty P. Synlett (2002) 703-706
72. Doig S.D., O'Sullivan L.M., Patel S., Ward J., and Woodley J.M. Enzyme Macrib. Technol. 28 (2001) 265-274
73. Cheesman M.J., Kneller M.B., Kelly E.J., Thompson S.J., Yeung C.K., Eaton D.L., and Rettie A.E. Protein Expression and Purif. 21 (2001) 81-86
74. Mihovilovic M.D., Müller B., and Stanetty P. Eur. J. Org. Chem. (2002) 3711-3730
75. Mihovilovic M.D. Curr. Org. Chem. 10 (2006) 1265-1287 NOTE. By 2005, a collection of available BVMOs allowed access to enantiocomplementary lactones for structurally diverse compounds, for details see Refs. 78 and 86a
76. Gonzalez D., Schapiro V., Seoane G., and Hudlicky T. Tetrahedron: Asymmetry 8 (1997) 975-977
77. Hudlicky T., and Reed J.W. In: Hassner A. (Ed). Advances in Asymmetric Synthesis Vol. 1 (JAI, 1995) pp 271-312
78. Zylstra G.J., and Gibson D.T. J. Biol. Chem. 264 (1989) 14940-14946
79. Herrmann G.F., Wang P., Shen G.-J., Garcia-Junceda E., Khan S.H., Matta K.L., and Wong C.-H. J. Org. Chem. 59 (1994) 6356-6362
80. Burkart M.D. Org. Biomol. Chem. 1 (2003) 1-4
81. Kayser M.M., Zhao H., Chen G., and Feicht A. ARKIVOC 12 (2002) 47-62
82. The recombinant strains such as E. coli [BL21(DE3)(pMM4)] that overexpress CHMO at a level ca. 20% of total protein (Ref. 30) or the inexpensive l-arabinose inducible E. coli TOP10 [pQR239] (Ref. 33a).
83. Sheng D., Ballou D.P., and Massey V. Biochemistry 40 (2001) 11156-11167
84. van der Donk W.A., and Zhaoz H. Curr. Opin. Biotechnol. 14 (2003) 421-426
85. Rissom S., Schwarz-Linek U., Vogel M., Tishkov V.I., and Kragl U. Tetrahedron: Asymmetry 8 (1997) 2523-2526
86. Tishkov V.I., Galkin A.G., Fedorchuk V.V., Savitsky P.A., Rojkova A.M., Gieren H., and Kula M.R. Biotechnol. Bioeng. 64 (1999) 187-193
87. Schwarz-Linek U., Krodel A., Ludwig F.-A., Schulze A., Rissom S., Kragl U., Tishkov V.I., and Vogel M. Synthesis 6 (2001) 947-951
88. Zambianchi F., Pasta P., Carrea G., Colonna S., Gaggero N., and Woodley J.M. Biotechnol. Bioeng. 78 (2002) 489-496
89. Atia K.S. Radiat. Phys. Chem. 73 (2005) 91-99
90. Enzymes coupled with inorganic carriers are generally more stable than those attached to organic polymers.
91. Secundo F., Zambianchi F., Crippa G., Carrea G., and Tedeschi G. J. Mol. Catal. B: Enzym. 34 (2005) 1-6
92. Willetts A. Trends Biotechnol. 15 (1997) 55-62
93. Walsh C.T., and Chen Y.-C.J. Angew. Chem., Int. Ed. Engl. 27 (1988) 333-343
94. Ottolina G., Pasta P., Carrea G., Colonna S., Dallavale S., and Holland H.L. Tetrahedron: Asymmetry 6 (1995) 1375-1386
95. Colonna S., Gaggero N., Carrea G., and Pasta P. Chem. Commun. (1997) 439-440
96. Ottolina G., Pasta P., Varley D., and Holland H.L. Tetrahedron: Asymmetry 7 (1996) 3427-3430
97. Colonna S., Gaggero N., Pasta P., and Ottolina G. Chem. Commun. (1996) 2303-2307
98. Colonna S., Gaggero N., Bertinotti A., Carrea G., Pasta P., and Bernardi A. J. Chem. Soc., Chem. Commun. (1995) 1123-1124
99. Colonna S., Gaggero N., Carrea G., and Pasta P. Chem. Commun. (1998) 415-416
100. Colonna S., Pironti V., Pasta P., and Zambianchi F. Tetrahedron Lett. 44 (2003) 869-871
101. Colonna S., Gaggero N., Carrea G., Ottolina G., Pasta P., and Zambianchi F. Tetrahedron Lett. 43 (2002) 1797-1799
102. Mihovilovic M.D., Rudroff F., Kandioller W., Grotzl B., Stanetty P., and Spreitzer H. Synlett (2003) 1973-1976
103. Wang S., Chen G., Kayser M.M., Iwaki H., Lau P.C.K., and Hasegawa Y. Can. J. Chem. 80 (2002) 613-621
104. Turner N.J. Curr. Opin. Chem. Biol. 8 (2004) 114-119
105. Berezina N., Alphand V., and Furstoss R. Tetrahedron: Asymmetry 18 (2002) 1953-1955
106. Gutiérrez M.-C., Furstoss R., and Alphand V. Adv. Synth. Catal. 347 (2005) 1051-1059
107. Alphand V., and Furstoss R. J. Org. Chem. 57 (1992) 1306-1309
108. Watanabe A., Uchida T., Irie R., and Katsuki T. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 5737-5742
109. Černuchová P., and Mihovilovic M.D. Org. Biomol. Chem. 5 (2007) 1715-1719
110. Griffin M., and Trudgill P.W. Eur. J. Biochem. 63 (1976) 199-209
111. Bradshaw W.H., Conrad H.E., Corey E.J., Gunsalus I.C., and Lednicer D. J. Am. Chem. Soc. 81 (1959) 5507
112. Brzostowicz P.C., Gibson K.L., Thomas S.M., Blasko M.S., and Rouvière P.E. J. Bacteriol. 182 (2000) 4241-4248 NOTE. The two cyclohexanone monooxygenase genes identified in Brevibacterium HCU belong to the family of flavin NADPH dependent monooxygenases. The closest relatives of the two enzymes, the Acinetobacter cyclohexanone monooxygenase and a Rhodococcus steroid monooxygenase, show divergence with amino acid identity between 35% and 40%. The significance of the two isozymes of the cyclohexanone monooxygenase is not known, although it may be related to their different substrate specificities
113. Bramucci, M.G.; Brzostowicz, P.C.; Kostichka, K.N.; Nagarajan, V.; Rouviere, P.E.; Thomas S.M. (E.I. DuPont de Nemours & Co., USA.). WO2003020890, 2003.
114. Brachy
115. Brevi2)
116. Rhodo2)
117. Itagaki E. J. Biochem. 99 (1986) 815-824
118. Morii S., Sawamoto S., Yamauchi Y., Miyamoto M., Iwami M., and Itagaki E. J. Biochem. 126 (1999) 624-631
119. Kostichka K., Thomas S.M., Gibson K.J., Nagarajan V., and Cheng Q. J. Bacteriol. 183 (2001) 6478-6486
120. Kamerbeek N.M., Moonen M.J., Van Der Ven J.G., Van Berkel W.J.H., Fraaije M.W., and Janssen D.B. Eur. J. Biochem. 268 (2001) 2547-2557
121. Kamerbeek N.M., Olsthoorn A.J.J., Fraaije M.W., and Janssen D.B. Appl. Environ. Microbiol. 69 (2003) 419-426
122. Iwaki N., Hasegawa Y., Wang S., Kayser M.M., and Lau P.C.K. Appl. Environ. Microbiol. 68 (2002) 5671-5684
123. Kyte B.G., Rouvière P., Cheng Q., and Stewart J.D. J. Org. Chem. 69 (2004) 12-17 also see Ref. 86d
124. Enantiomeric ratio or 'E value' reflects the relative rates of reaction of the (R)- and (S)-enantiomer. The equations for calculating E value were developed by Sih and coworkers in 1982 (. Chen C.-S., Fujimoto Y., Girdaukas G., and Sih C.J. J. Am. Chem. Soc. 104 (1982) 7294-7299. http://borgc185.kfunigraz.ac.at ). Today E value can be calculated using free shareware programs for calculation of the enantiomeric ratio, available from the authors K. Faber, H. Hönnig, A. Kleewein, website:
125. Mihovilovic M.D., Rudroff F., Müller B., and Stanetty P. Bioorg. Med. Chem. Lett. 13 (2003) 1479-1482
126. See Ref. 60.
127. Bes M.T., Villa R., Roberts S.M., Wan P.W.H., and Willetts A. J. Mol. Catal. B: Enzym. 1 (1996) 127-134
128. Wang S., Kayser M.M., Iwaki H., and Lau P.C.K. J. Mol. Catal. B: Enzym. 22 (2003) 211-218
129. Mihovilovic M.D., Müller B., Kayser M.M., Stewart J.D., and Stanetty P. Synlett (2002) 703-706
130. Mihovilovic M.D., Müller B., Schulze A., Stanetty P., and Kayser M.M. Eur. J. Org. Chem. (2003) 2243-2249
131. Mihovilovic M.D., Rudroff F., Grötzl B., and Stanetty P. Eur. J. Org. Chem. (2005) 809-816
132. Wang S., Kayser M.M., and Jurkauskas V. J. Org. Chem. 68 (2003) 6222-6228
133. Mihovilovic M.D., Rudroff F., Grotzl B., Kapitan P., Snajdrova R., Rydz J., and Mach R. Angew. Chem., Int. Ed. 44 (2005) 3609-3613
134. Mihovilovic M.D., Kapitàn P., and Kapitànovà P. ChemSusChem 1 (2008) 143-148
135. Mihovilovic M.D., and Kapitàn P. Tetrahedron Lett. 45 (2004) 2751-2754
136. Rudroff F., Rydz J., Ogink F.H., Fink M., and Mihovilovic M.D. Adv. Synth. Catal. 349 (2007) 1436-1444
137. Rial D.V., Bianchi D.A., Kapitanova P., Lengar A., Van Beilen J.B., and Mihovilovic M.D. Eur. J. Org. Chem. (2008) 1203-1213
138. Rial D.V., Cernuchova P., Van Beilen J.B., and Mihovilovic M.D. J. Mol. Catal. B: Enzym. 50 (2008) 61-68
139. van Beilen J.B., Seeger J.B.F.M.A., Kovac J., Li J.Z., Smits T.H.M., Fritsche U., and Witholt B. Environ. Microbiol. 5 (2003) 174-182
140. Xantho is FMN- and NADPH-dependent and cannot be classified as Type I or Type II enzyme (. Trower M.K., Buckland R.M., and Griffin M. Eur. J. Biochem. 181 (1989) 199-206 )
141. Cripps R.E. Biochem. J. 152 (1975) 233-241
142. Moonen M.J.H., Rietjens I.M.C.M., and Van Berkel W.J.H. In: Ghisla S., Kroneck P., Macheroux P., and Sund H. (Eds). Flavins and Flavoproteins (1999), Scientific, Berlin
143. Tanner A., and Hopper D.J. J. Bacteriol. 182 (2000) 6565-6569
144. Mihovilovic M.D., Kapitan P., Rydz J., Rudroff F., Ogink F.H., and Fraaije M.W. J. Mol. Catal. B: Enzym. 32 (2005) 135-140
145. Peterson D.H., Eppstein S.H., Meister P.D., Murray H.C., Leigh H.M., Weintraub A., and Reineke L.M. J. Am. Chem. Soc. 75 (1953) 5768-5769
146. Braunstein G.D. Endocr. Relat. Cancer 6 (1999) 315-324
147. Feuillan P., Merke D., Leschek E.W., and Cutler G.B. Endocr. Relat. Cancer 6 (1999) 303-306
148. Seralini G.E., and Moslemi S. Mol. Cell. Endocrinol. 178 (2001) 117-131
149. Sebek O.K., Reineke L.M., and Peterson D.H. J. Bacteriol. 83 (1962) 1327-1331
150. Prairie R.L., and Talalay P. Biochemistry 2 (1963) 203-208
151. Fonken G.S., Murray H.C., and Reineke L.M. J. Am. Chem. Soc. 82 (1960) 5507-5508
152. Liua H.-M., Li H., Shana L., and Wu J. Steroids 71 (2006) 931-934
153. Schumacher J.D., and Fakoussa R.M. Appl. Microbiol. Biotechnol. 52 (1999) 85-90
154. See Ref. 73.
155. Kirschner A., Altenbuchner J., and Bornscheuer U.T. Appl. Microbiol. Biotechnol. 73 (2007) 1065-1072
156. Kirschner A., and Bornscheuer U. Angew. Chem., Int. Ed. 45 (2006) 7004-7006
157. Britton L.N., and Markovetz A.J. J. Biol. Chem. 252 (1977) 8561-8566
158. Fraaije M.W., Wu J., Heuts D.P.H.M., Van Hellemond E.W., Spelberg J.H.L., and Janssen D.B. Appl. Microbiol. Biotechnol. 66 (2005) 393-400
159. de Gonzalo G., Torres Pazmiño D.E., Ottolina G., Fraaije M.W., and Carrea G. Tetrahedron: Asymmetry 16 (2005) 3077-3083
160. Rodri{dotless}guez C., de Gonzalo G., Fraaije M.W., and Gotor V. Tetrahedron: Asymmetry 18 (2007) 1338-1344 PAMO
161. Iwaki H., Wang S., Grosse S., Bergeron H., Nagahashi A., Lertvorachon J., Yang J., Konishi Y., Hasegawa Y., and Lau P.C.K. Appl. Environ. Microbiol. 72 (2006) 2707-2720
162. Eswaramoorthy S., Bonnano J.B., Burley S.K., and Swaminathan S. PNAS 103 (2006) 9832-9837
163. Fraaije M.W., Kamerbeek N.M., van Berkel W.J.J., and Janssen D.B. FEBS Lett. 518 (2002) 43-47
164. Vannelli T.A., Dykman A., and Ortiz de Montellano P.R. J. Biol. Chem. 277 (2002) 12824-12829
165. Bonsor D., Butz S.F., Solomons J., Grant S., Fairlamb I.J.S., Fogg M.J., and Grogan G. Org. Biomol. Chem. 4 (2006) 1252-1260
166. Snajdrova R., Grogan G., and Mihovilovic M.D. Bioorg. Med. Chem. Lett. 16 (2006) 4813-4817
167. Excellent reviews on directed evolution:. Farinas E.T., Bulter T., and Arnold F.H. Curr. Opin. Biotechnol. 12 (2001) 545-551
168. Arnold F.H. Nature 409 (2001) 253-257
169. Reetz M.T. Angew. Chem., Int. Ed. 40 (2001) 284-310
170. Jaeger K.-E., Eggert T., Eipper A., and Reetz M.T. Appl. Microbiol. Biotechnol. 55 (2001) 519-530
171. Brakmann S., and Johnsson K. Directed Molecular Evolution of Proteins (2002), Wiley-VCH, Weinheim, Germany
172. Malito E., Alfieri A., Fraaije M.W., and Mattevi A. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 13157-13162
173. Taschner M.J., Peddada L., Cyr P., Chen Q.Z., and Black D.J. In: Servi S. (Ed). Microbial Reagents in Organic Synthesis. NATO ASI Series, Series C (1992), Kluwer Academic, Dordrecht 347-360
174. Alphand V., and Furstoss R. Tetrahedron: Asymmetry 3 (1992) 379-382
175. Furstoss R. In: Servi S. (Ed). Microbial Reagents in Organic Synthesis. NATO ASI Series, Series C (1992), Kluwer Academic, Dordrecht 333-346
176. Wright M., Knowles C., Petit F., and Furstoss R. Biotechnol. Lett. 16 (1994) 1287-1292
177. Kelly D.R., Knowles C.J., Mahdi J.G., Wright M.A., Taylor I.N., Hibbs D.E., Hursthouse M.B., Mish'al A.K., Roberts S.M., Wan P.W.H., Grogan G., and Willetts A.J. J. Chem. Soc., Perkin Trans. 1 (1995) 2057-2066
178. See Ref. 53.
179. See Ref. 55.
180. Ottolina G., Carrea G., Colonna S., and Ruckermann A. Tetrahedron: Asymmetry 7 (1996) 1123-1136
181. Prelog V. Pure Appl. Chem. 9 (1964) 119-130
182. Sylvestre J., Chautard H., Cedrone F., and Delcourt M. Org. Process Res. Dev. 10 (2006) 562-571
183. In: Arnold F.H., and Georgiou G. (Eds). Directed Enzyme Evolution: Screening and Selection Methods Vol. 230 (2003), Humana, Totowa, NJ
184. Reviews on directed evolution of enzymes for biocatalysis:
185. Reetz M.T. In: Gates B.C., and Knozinge H. (Eds). Advances in Catalysis Vol. 49 (2006), Elsevier, San Diego, CA 1-69
186. Jaeger K.-E., and Eggert T. Curr. Opin. Biotechnol. 15 (2004) 305-313
187. Leung D.W., Chen E., and Goeddel D.V. Technique (Philadelphia) 1 (1989) 11-15
188. Cadwell R.C., and Joyce G.F. PCR Methods Appl. 2 (1992) 28-33
189. Reetz M.T. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 5716-5722
190. Reetz M.T., and Jaeger K.-E. In: Brakmann S., and Johnsson K. (Eds). Directed Molecular Evolution of Proteins (2002), Wiley-VCH, Weinheim 245-280
191. Reetz M.T., Torre C., Eipper A., Lohmer R., Hermes M., Brunner B., Maichele A., Bocola M., Arand M., Cronin A., Genzel Y., Archelas A., and Furstoss R. Org. Lett. 6 (2004) 177-180
192. Reetz M.T., Brunner B., Schneider T., Schulz F., Clouthier C.C., and Kayser M.M. Angew. Chem., Int. Ed. 43 (2004) 4075-4078
193. Kayser M.M., and Clouthier C.M. J. Org. Chem. 71 (2006) 8424-8430
194. Mihovilovic M.D., Rudroff F., Winninger A., Schneider T., Schulz F., and Reetz M.T. Org. Lett. 8 (2006) 1221-1224
195. Reetz M.T., Daligault F., Brunner B., Hinrichs H., and Degee A. Angew. Chem., Int. Ed. 43 (2004) 4078-4081
196. Bocola M., Schultz F., Leca F., Vogel A., Fraaije M.W., and Reetz M.T. Adv. Synth. Catal. 347 (2005) 979-986
197. Lund, O.; Nielsen, M.; Lundegaard, C.; Worning, P. X3M: A Computer Program to Extract 3D Models. Abstract at the CASP5 Conference, Livermore, CA, USA, 2002; A102.
198. Torres Pazmiño D.E., Snajdrova R., Rial D.V., Mihovilovic M.D., and Fraaije M.W. Adv. Synth. Catal. 349 (2007) 1361-1368
199. Ottosson J., Rotticci-Mulder J.C., Rottici D., and Hult K. Protein Sci. 10 (2001) 1769-1774
200. Morley K.L., and Kazlauskas R.J. Trends Biotechnol. 23 (2005) 231-237
201. James L.C., and Tawfik D.S. Trends Biochem. Sci. 28 (2003) 361-368
202. Dalby P.A. Curr. Opin. Struct. Biol. 13 (2003) 500-505
203. Chica R.A., Doucet N., and Pelletier J.N. Curr. Opin. Biotechnol. 16 (2005) 378-384
204. Reetz M.T., Bocola M., Carballeira J.D., Zha D., and Vogel A. Angew. Chem., Int. Ed. 44 (2005) 4192-4196
205. Reetz M.T., Wang L.-W., and Bocola M. Angew. Chem., Int. Ed. 45 (2006) 1236-1241 Corrigendum, 2494
206. Reetz M.T., Carballeira J.D., Peyralans J., Höbenreich H., Maichele A., and Vogel A. Chem.-Eur. J. 12 (2006) 3061-3068
207. Clouthier C.M., Kayser M.M., and Reetz M.T. J. Org. Chem. 71 (2006) 8431-8437
208. Models were constructed using CPHmodel 2.032 and refined using Moloc, a molecular mechanics program that relaxes the structures:
209. Gerber P.R., and Muller K. J. Comput.-Aided Mol. Des. 9 (1995) 251-268
210. Gerber P.R. J. Comput.-Aided Mol. Des. 12 (1998) 37-51 NOTE. Models are based on the X-ray structure of PAMO (not CHMO or CPMO) and not include NADPH. This structure does not reflect the dynamic component of the enzyme in the catalytically important Crigee intermediate formation step. It is important, therefore, to keep in mind that although models are useful they are only models
211. Kayser M.M., and Clouthier C. Tetrahedron: Asymmetry 17 (2006) 2649-2653
212. Kamerbeek N.M., Fraaije M.W., and Janssen D.B. Eur. J. Biochem. 271 (2004) 1-10
213. Stewart J.D. In: Patel R.N., and Ramesh (Eds). Biocatalysis in the Pharmaceutical and Biotechnology Industries (2007), CRC LLC, Boca Raton, FL 333-350
214. Stewart J.D. In: Sariaslani S. (Ed). Advances in Microbiology Vol. 59 (2006), Elsevier, San Diego, CA 31-52
215. Feske B.D., Kaluzna I.A., and Stewart J.D. J. Org. Chem. 70 (2005) 9654-9657
216. Zhu D., Yang Y., Buynak J.D., and Hua L. Org. Biomol. Chem. 4 (2006) 2690-2695
217. Walton A.Z., and Stewart J.D. Biotechnol. Prog. 18 (2002) 262-268 NOTE. Detailed experimental
218. Walton A.Z., and Stewart J.D. Biotechnol. Prog. 20 (2004) 403-411
219. Review:. Kobayashi M., and Shimizu S. Curr. Opin. Chem. Biol. 4 (2000) 95-102
220. Clouthier C.M., and Kayser M.M. J. Mol. Catal. B: Enzym. 46 (2007) 32-36
221. Alphand V., Carrea G., Wohlgemuth R., and Furstoss R. Trends Biotechnol. 21 (2003) 318-323
222. Hilker I., Alphand V., Wohlgemuth R., and Furstoss R. Adv. Synth. Catal. 346 (2004) 203-214 (Reactor design and detailed experimental)
223. Hilker I., Gutiérrez M.C., Alphand V., Wohlgemuth R., and Furstoss R. Org. Lett. 6 (2004) 1955-1958
224. Hilker I., Alphand V., Wohlgemuth R., and Furstoss R. Biotechnol. Bioeng. 92 (2005) 702-710
225. Rudroff F., Alphand V., Furstoss R., and Mihovilovic M.D. Org. Process Res. Dev. 10 (2006) 599-604 (Good experimental details)
226. Schultz F., Leca F., Hollmann F., and Reetz M.T. Beilstein J. Org Chem. 1 (2005). http://bjoc.beilstein-journals.org/content/1/1/10 Available from:
227. Burdette D.S., Tchernajencko V., and Zeikus J.G. Enzyme Microb. Technol. 27 (2000) 11-18
228. The detailed experimental procedure is available as supplementary material online: http://www.biomedcentral.com/content/supplementary/1860-5397-1-10-S1.doc .
229. de Gonzalo G., Ottolina G., Zambianchi F., Fraaije M.W., and Carrea G. J. Mol. Catal. B: Enzym. 39 (2006) 91-97
230. Carrea G., and Riva S. Angew. Chem., Int. Ed. 39 (2000) 2226-2254
231. Hogan M.C., and Woodley J.M. Chem. Eng. Sci. (2000) 2001-2008
232. Zambianchi F., Pasta F., Carrea G., Colonna S., Gaggero N., and Woodley J.M. Biotechnol. Bioeng. 78 (2002) 489-496
233. Torres Pazmiño D.E., Snajdrova R., Baas B.-J., Ghobrial M., Mihovilovic M.D., and Fraaije M.W. Angew. Chem., Int. Ed. 47 (2008) 2275-2278
234. Costas A.M., White A.K., and Metcalf W.W. J. Biol. Chem. 276 (2001) 17429-17436
235. Vrtis J.M., White A.K., Metcalf W.W., and van der Donk W.A. Angew. Chem., Int. Ed. 41 (2002) 3257-3259
236. Hollmann F., Taglieber A., Schulz F., and Reetz M.T. Angew. Chem., Int. Ed. 46 (2007) 2903-2906
237. Taglieber A., Schulz F., Hollmann F., Rusek M., and Reetz M.T. ChemBioChem 9 (2008) 565-572
238. 165
239. Newton R.F., and Roberts S.M. Tetrahedron 36 (1980) 2163-2196
240. Lebreton J., Alphand V., and Furstoss R. Tetrahedron Lett. 37 (1996) 1011-1014
241. Lebreton J., Alphand V., and Furstoss R. Tetrahedron 53 (1996) 145-160
242. Andrau L., Lebreton J., Viazzo P., Alphand V., and Furstoss R. Tetrahedron Lett. 38 (1997) 825-826
243. Grogan G., Roberts S.M., and Willetts A.J. J. Chem. Soc., Chem. Commun. (1993) 691-701
244. Grogan G., Roberts S., Wan P., and Willetts A. Biotechnol. Lett. 15 (1993) 913-918 (DKCMO: Camphore degrading BVMOs: see Ref. 67)
245. Canan Koch S.S., and Chamberlin A.R. J. Org. Chem. 58 (1993) 2725-2737 and references therein
246. Mazzini C., Lebreton J., Alphand V., and Furstoss R. Tetrahedron Lett. 38 (1997) 1195-1196 Baclofen
247. C. echinulata (Thaxter), DSM 1905; other collections: ATCC 36190, NRRL 11498, NRRL 3655.
248. Alphand V., and Furstoss R. J. Mol. Catal. B: Enzym. 9 (2000) 209-217 Optimization of biotransformation conditions with C. echinulata
249. Mazzini C., Lebreton J., Alphand V., and Furstoss R. J. Org. Chem. 62 (1997) 5215-5218
250. Alphand V., Mazzini Cl., Lebreton J., and Furstoss R. J. Mol. Catal. B: Enzym. 5 (1998) 219-221
251. Honda T., Kimura N., Sato S., Kato D., and Tominaga H. J. Chem. Soc., Perkin Trans. 1 (1994) 1043-1046 and references herein
252. Tanaka M., Mukaiyama C., Mitsuhashi H., Maruno M., and Wakamatsu T. J. Org. Chem. 60 (1995) 4339-4352
253. Reusser F. Infect. Immun. 2 (1970) 77-81
254. Taschner M.J., and Aminbhavi A.S. Tetrahedron Lett. 30 (1989) 1029-1032
255. Smith III A.B., Friestad G.K., Barbosa J., Bertounesque E., Hull K.G., Iwashima M., Qiu Y., Salvatore B.A., Spoors P.G., and Duan J.J.-W. J. Am. Chem. Soc. 121 (1999) 10468-10477
256. Mihovilovic M.D., Bianchi D.A., and Rudroff F. Chem. Commun. (2006) 3214-3216
257. Mihovilovic M.D., Grçtzl B., Kandiollera W., Muskotal A., Snajdrova R., Rudroff F., and Spreitzer H. Chem. Biodivers. 5 (2008) 490-498
258. Brenna E., Fuganti C., and Serra S. Tetrahedron: Asymmetry 14 (2003) 1-42
259. Corey E.J., Pyne S.G., and Su W.-G. Tetrahedron Lett. 24 (1983) 4883-4886
260. White J.D., and Jensen M.S. J. Am. Chem. Soc. 117 (1995) 6224-6233
261. Prasad K.R., and Pazhamalai A. Tetrahedron: Asymmetry 18 (2007) 2479-2483
262. Ferreira-Torres C., Micheletti M., and Lye G.J. Bioprocess Biosyst. Eng. 28 (2005) 83-93
263. Mihovilovic M.D., Snajdrova R., Winninger A., and Rudroff F. Synlett (2005) 2751-2754
264. Torres Pazmiño D.E., Baas B.-J., Janssen D.B., Marco W., and Fraaije. Biochemistry 47 (2008) 4082-4093
265. Seong-Hoon K., Tamao H., Kazuki T., Wakana I., Akio E., and Kunio M. J. Biol. Chem. 282 (2007) 33107-33117
266. Reetz M.T., and Sanchis J. ChemBioChem 9 (2008) 2260-2267
267. Reetz M.T., Kahakeaw D., and Lohmer R. ChemBioChem 9 (2008) 1797-1804
268. Cyclohexanone Monooxygenase from Nocardia globerula, Cyclohexanone Monooxygenase from Acinetobacter sp., Cyclohexanone Monooxygenase from Xanthobacter sp., Cyclopentanone Monooxygenase from Pseudomonas sp. are available from Sigma-Aldrich. The overexpression systems for other BVMOs are not, to my knowledge, commercially produced. However, approaching the research group that has constructed and/or worked with the desired bioreagent may lead to a successful collaboration.